Anebulo Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Anebulo Pharmaceuticals has a total shareholder equity of $1.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $2.5M and $569.2K respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$1.40m |
| Equity | US$1.90m |
| Total liabilities | US$569.23k |
| Total assets | US$2.47m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 214's short term assets ($2.0M) exceed its short term liabilities ($569.2K).
Long Term Liabilities: 214 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 214 is debt free.
Reducing Debt: 214 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 214 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 214 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 22.3% each year